XML 56 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Equity
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Equity

Note 10 - Equity

Options

In 2010, the Company’s shareholders approved the adoption of a stock and option award plan (the “2010 Plan”), under which 11.7 million shares were reserved for future equity awards as further defined by the 2010 Plan.  In addition, the 2010 Plan permits grants of equity awards to employees, directors and consultants. A total of 3.7 million shares remain available for future equity awards as of September 30, 2019.

The following table summarizes the activity of the 2010 Plan and the available options to be granted as of September 30, 2019:

 

 

 

 

 

    

2010 Plan

 

 

 

 

Total shares reserved for equity awards

 

 

11,700,000

Options granted

 

 

(14,429,757)

Add back: expired, forfeited and/or cancelled equity awards

 

 

6,264,655

Add back: options used in net exercise

 

 

192,385

Remaining shares available for future equity awards

 

 

3,727,283

 

During the nine months ended September 30, 2019, the Company granted to employees and certain non-employee directors 2,052,500 stock options at a weighted average exercise price of $0.58. Other stock option activity during this period included the cancelation and expiration of 1,550,000 options and 15,000 options, respectively.  There were no stock option exercises or forfeitures during this period.

The following table summarizes the Company’s stock option activity during this period:

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

Weighted Average

    

 

 

 

 

Number of

 

Average

 

Remaining

 

 

Aggregate

 

 

Options

 

Exercise Price

 

Contractual Life

 

 

Intrinsic Value

Outstanding at December 31, 2018

 

5,426,165

 

$

1.99

 

4.89

 

$

 —

Granted

 

2,052,500

 

$

0.58

 

 

 

 

 

Exercised

 

 —

 

$

 —

 

 

 

 

 

Forfeited

 

 —

 

$

 —

 

 

 

 

 

Expired and/or Cancelled

 

(1,565,000)

 

$

2.60

 

 

 

 

 

Outstanding at September 30, 2019

 

5,913,665

 

$

1.34

 

5.51

 

$

42,603

Exercisable at September 30, 2019

 

5,451,163

 

$

1.41

 

5.21

 

$

26,108

 

Stock options outstanding at September 30, 2019 are summarized in the table below:

 

 

 

 

 

 

 

 

 

    

Number of

    

Weighted

    

Weighted Average

 

 

Options

 

Average

 

Remaining

Range of Exercise Prices

 

Outstanding

 

Exercise Price

 

Contractual Lives

$0.40 - $2.00

 

4,885,923

 

$

0.75

 

6.14

$2.01 - $5.00

 

840,000

 

$

3.28

 

2.18

$5.01 - $8.62

 

187,742

 

$

7.97

 

4.10

 

 

5,913,665

 

$

1.34

 

5.51

 

The Company computes the fair value for all options granted or modified using the Black-Scholes option pricing model. To calculate the fair value of the options, certain assumptions are made regarding components of the model, including the fair value of the underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company calculates its volatility assumption using the actual changes in the market value of its stock. Forfeitures are recognized as they occur. The Company’s historical option exercises do not provide a reasonable basis to estimate an expected term due to the lack of sufficient data. Therefore, the Company estimates the expected term by using the simplified method. The simplified method calculates the expected term as the average of the vesting term plus the contractual life of the options. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of the grant for treasury securities of similar maturity. The Company computed the fair value of options granted and modified during the period ended September 30, 2019, using the following assumptions:

 

 

 

 

Expected volatility

    

130.05 % - 186.92

%

Risk free interest rate

 

1.42% - 2.38

%

Expected term (years)

 

1.00 - 5.00

 

Dividend yield

 

0.0

%

 

Stock-based compensation expense related to the fair value of stock options is included in the statements of operations as research and development expenses or general and administrative expenses as set forth in the table below. The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

 

    

2019

    

2018

    

2019

    

2018

Research and development expenses

 

 

  

 

 

  

 

 

  

 

 

  

Stock-based compensation

 

$

46,000

 

$

20,000

 

$

77,000

 

$

73,000

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

 

 

 

  

 

 

  

 

 

  

Issuance of common stock for services

 

 

 —

 

 

 —

 

 

60,000

 

 

60,000

Stock-based compensation

 

 

209,000

 

 

75,000

 

 

278,000

 

 

214,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock-based compensation

 

$

255,000

 

$

95,000

 

$

415,000

 

$

347,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrecognized expense at September 30, 2019

 

$

44,000

 

 

  

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining years to vest

 

 

0.66